Beta-blocker continuation versus interruption during transcatheter aortic valve implantation: Rationale and design of the BETA-TAVI randomized trial. // Cardiovascular Revascularization Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S1553838926004604?dgcid=rss_sd_all
Beta-blocker continuation versus interruption during transcatheter aortic valve implantation: Rationale and design of the BETA-TAVI randomized trial. Cardiovascular Revascularization Medicine. https://www.sciencedirect.com/science/article/pii/S1553838926004604?dgcid=rss_sd_all
“Beta-blocker continuation versus interruption during transcatheter aortic valve implantation: Rationale and design of the BETA-TAVI randomized trial.” Cardiovascular Revascularization Medicine.
@article{article39757,
title = {Beta-blocker continuation versus interruption during transcatheter aortic valve implantation: Rationale and design of the BETA-TAVI randomized trial},
journal = {Cardiovascular Revascularization Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S1553838926004604?dgcid=rss_sd_all}
}